Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP
Report ID | 50924 |
Drug Identification Number | 02139499 |
Brand name | MAGNESIUM SULFATE INJECTION |
Common or Proper name | Magnesium Sulphate |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MAGNESIUM SULFATE |
Strength(s) | 500MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-05-28 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-10-24 |
Shortage status | Resolved |
Updated date | 2018-10-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2018-10-25 | French | Compare |
v8 | 2018-10-25 | English | Compare |
v7 | 2018-10-25 | English | Compare |
v6 | 2018-10-25 | English | Compare |
v5 | 2018-10-24 | English | Compare |
v4 | 2018-07-16 | French | Compare |
v3 | 2018-07-16 | English | Compare |
v2 | 2018-05-30 | French | Compare |
v1 | 2018-05-30 | English | Compare |
Showing 1 to 9 of 9